JP2017514825A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017514825A5 JP2017514825A5 JP2016565157A JP2016565157A JP2017514825A5 JP 2017514825 A5 JP2017514825 A5 JP 2017514825A5 JP 2016565157 A JP2016565157 A JP 2016565157A JP 2016565157 A JP2016565157 A JP 2016565157A JP 2017514825 A5 JP2017514825 A5 JP 2017514825A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- combination according
- composition
- sulfated
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 210000003491 Skin Anatomy 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000000699 topical Effects 0.000 claims 4
- 239000002537 cosmetic Substances 0.000 claims 3
- 150000004676 glycans Polymers 0.000 claims 3
- 229920002674 hyaluronan Polymers 0.000 claims 3
- 229960003160 hyaluronic acid Drugs 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- 150000004804 polysaccharides Polymers 0.000 claims 3
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 claims 1
- 206010049796 Excoriation Diseases 0.000 claims 1
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 claims 1
- 206010039580 Scar Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 206010040882 Skin lesion Diseases 0.000 claims 1
- 206010042496 Sunburn Diseases 0.000 claims 1
- 206010053615 Thermal burn Diseases 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003712 anti-aging Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 230000002225 anti-radical Effects 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000003908 antipruritic agent Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000007854 depigmenting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000037149 energy metabolism Effects 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- 230000000887 hydrating Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 235000020945 retinal Nutrition 0.000 claims 1
- 239000011604 retinal Substances 0.000 claims 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000037387 scars Effects 0.000 claims 1
- 231100000444 skin lesion Toxicity 0.000 claims 1
- 230000004936 stimulating Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
Claims (16)
- ヒアルロン酸またはその塩と、硫酸化フカン類および硫酸化ウルバン類から選択される５〜２５ｋＤａの間の分子量を有する硫酸化多糖とを含んでなる組合せ。
- 前記ヒアルロン酸またはその塩が、５０〜７５０ｋＤａの間の重量平均分子量を有する、請求項１に記載の組合せ。
- 前記重量平均分子量が６０〜１２０ｋＤａの間である、請求項２に記載の組合せ。
- ５〜２５ｋＤａの間の分子量を有する前記硫酸化多糖が硫酸化フカンである、請求項１〜３のいずれか一項に記載の組合せ。
- 多糖に対するヒアルロン酸の質量比率が０．１〜１０の間である、請求項１〜４のいずれか一項に記載の組合せ。
- 繊維芽細胞の増殖を促進するための、請求項１〜５のいずれか一項に記載の組合せを含んでなる局所用組成物。
- 皮膚加齢の兆候に対処するための、請求項１〜５のいずれか一項に記載の組合せを含んでなる局所用組成物。
- 皮膚病変を処置するための、請求項１〜５のいずれか一項に記載の組合せを含んでなる局所用組成物。
- 皮膚の治療および回復を改善するための、請求項１〜５のいずれか一項に記載の組合せを含んでなる局所用組成物。
- 有効成分として、請求項１〜５のいずれか一項に記載の組合せを、少なくとも１つの皮膚科学的または化粧品的に許容可能な賦形剤とともに含んでなる、皮膚科学または化粧組成物。
- 別の有効成分をさらに含んでなる、請求項１０に記載の組成物。
- 前記他の有効成分が、老化防止剤、治療剤、無痛化剤、鎮痒剤、抗ラジカル剤、ＵＶ防止剤、皮膚高分子の合成またはエネルギー代謝を刺激する剤、水和剤、脱色素剤、抗菌剤、抗真菌剤、抗炎症剤、麻酔剤およびそれらの混合物から選択される、請求項１１に記載の組成物。
- 前記他の有効成分がレチンアルデヒドである、請求項１１に記載の組成物。
- 前記他の有効成分がδ−トコフェリル−グルコピラノシドである、請求項１１に記載の組成物。
- 皮膚加齢の兆候に対処するための、請求項１０〜１４のいずれか一項に記載の化粧組成物。
- 切り傷、縫合、表皮剥脱、引掻き傷、擦り傷、外科手術後または美容皮膚科学的処置後の瘢痕、表在性熱傷、日焼けの処置における使用のための、請求項１０に記載の皮膚科学組成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1453973A FR3020570B1 (fr) | 2014-04-30 | 2014-04-30 | Association d'un acide hyaluronique et d'un polysaccharide sulfate |
| FR1453973 | 2014-04-30 | ||
| PCT/EP2015/059544 WO2015166063A1 (fr) | 2014-04-30 | 2015-04-30 | Association d'un acide hyaluronique et d'un polysaccharide sulfate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017514825A JP2017514825A (ja) | 2017-06-08 |
| JP2017514825A5 true JP2017514825A5 (ja) | 2018-06-07 |
| JP6625558B2 JP6625558B2 (ja) | 2019-12-25 |
Family
ID=50976947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565157A Active JP6625558B2 (ja) | 2014-04-30 | 2015-04-30 | ヒアルロン酸と硫酸化多糖との組合せ |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9993417B2 (ja) |
| EP (1) | EP3137050B1 (ja) |
| JP (1) | JP6625558B2 (ja) |
| KR (1) | KR20160145788A (ja) |
| CN (1) | CN106255490B (ja) |
| AU (1) | AU2015254602B2 (ja) |
| BR (1) | BR112016024161B1 (ja) |
| CA (1) | CA2946943C (ja) |
| FR (1) | FR3020570B1 (ja) |
| MX (1) | MX2016014050A (ja) |
| RU (1) | RU2683567C2 (ja) |
| WO (1) | WO2015166063A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106038355B (zh) * | 2016-07-21 | 2019-11-12 | 中国科学院海洋研究所 | 一种高硫酸化的海藻多糖在晒后修复面膜中的应用 |
| WO2019022250A1 (ja) * | 2017-07-28 | 2019-01-31 | 国立大学法人九州大学 | 水溶性有効成分の放出が制御された経皮吸収組成物 |
| FR3075644B1 (fr) * | 2017-12-27 | 2020-08-28 | Oreal | Oligosaccharides sulfates et leurs utilisations cosmetiques |
| CN108553481B (zh) * | 2018-05-25 | 2020-11-13 | 中国海洋大学 | 一种具有促进伤口愈合作用的糖类组合物及其应用 |
| WO2020019080A1 (en) * | 2018-07-27 | 2020-01-30 | Arc Medical Devices Inc. | Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions |
| FR3098723B1 (fr) * | 2019-07-18 | 2023-01-13 | Bionuclei | Traitement ecobiologique des effets secondaires de la radiotherapie. |
| RU2753638C2 (ru) * | 2020-01-24 | 2021-08-18 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НОВАСКИН" (ООО "Новаскин") | Гелевая композиция для обработки кожных покровов |
| FR3113236A1 (fr) * | 2020-08-05 | 2022-02-11 | Algues Et Mer | Fraction purifiée de fucoïdanes pour la préparation de compositions cosmétiques et/ou dermatologiques anti-age. |
| IT202000022477A1 (it) * | 2020-09-23 | 2022-03-23 | Sofar Swiss Sa | Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo |
| CN115040535B (zh) * | 2022-08-15 | 2022-12-16 | 华南理工大学 | 硫酸化透明质酸在制备预防角膜纤维化、角膜瘢痕滴眼液中的应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
| IL114914A0 (en) * | 1994-08-30 | 1995-12-08 | Hyal Pharma Corp | Modulation of cellular activity |
| FR2772618B1 (fr) * | 1997-12-18 | 2000-02-18 | Ifremer | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
| FR2775976B1 (fr) * | 1998-03-10 | 2000-06-02 | Fabre Pierre Dermo Cosmetique | Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase |
| US6572868B1 (en) * | 2000-07-25 | 2003-06-03 | Sandra E. Cope | Restructuring complex for cosmetic compositions |
| FR2829762B1 (fr) * | 2001-09-17 | 2004-02-13 | Fabre Pierre Dermo Cosmetique | Bioprecurseurs destines a une application percutanee |
| KR100485326B1 (ko) * | 2002-12-26 | 2005-04-27 | 주식회사 태평양 | 진세노사이드 화합물 ｋ로 이루어진 히알루론산 생성촉진제 |
| US6925626B2 (en) * | 2003-08-13 | 2005-08-02 | Lsi Logic Corporation | Method of routing a redistribution layer trace in an integrated circuit die |
| FR2865651B1 (fr) * | 2004-01-29 | 2007-09-28 | Fabre Pierre Dermo Cosmetique | Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale |
| AU2005272578A1 (en) * | 2004-08-13 | 2006-02-23 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyluronidase inhibitors |
| US20080038780A1 (en) | 2006-02-15 | 2008-02-14 | Novozymes Biopolymer A/S | Production of low molecular weight hyaluronic acid |
| FR2909560B1 (fr) | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
| DE102006060953A1 (de) * | 2006-12-12 | 2008-08-07 | Farco-Pharma Gmbh | Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes |
| KR20080087941A (ko) * | 2007-03-28 | 2008-10-02 | 주식회사 바이오랜드 | 저분자량 히알우론산을 함유하는 피부주름개선 및각질제거용 조성물 |
| JP5468757B2 (ja) * | 2007-09-04 | 2014-04-09 | ロート製薬株式会社 | 線維芽細胞増殖促進能を有する組成物 |
| CZ303471B6 (cs) * | 2007-10-03 | 2012-10-03 | Contipro Biotech S.R.O. | Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan |
| US7932237B2 (en) * | 2008-05-15 | 2011-04-26 | Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) | Pharmaceutical compositions for use in the treatment of wounds |
| KR20100025237A (ko) * | 2008-08-27 | 2010-03-09 | 주식회사 해림후코이단 | 후코이단을 함유하는 아토피성 피부용 보습제 |
| WO2010086696A1 (en) | 2009-01-28 | 2010-08-05 | Therapol | Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy |
| KR101149711B1 (ko) * | 2010-02-25 | 2012-06-08 | (주)코스비전 | 저분자 후코이단, 비타민나무 추출물 및 니아신아마이드가 함유된 피부 미백용 화장료 조성물 및 그 제조방법 |
| CA2790682C (en) * | 2010-03-03 | 2020-11-24 | Neocutis Sa | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| FR2958157B1 (fr) * | 2010-04-02 | 2012-06-29 | Libragen | Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate |
| FR2978664B1 (fr) * | 2011-08-04 | 2014-01-10 | Petcare Innovation | Composition antiseptique |
| JP5946253B2 (ja) * | 2011-08-10 | 2016-07-06 | ロート製薬株式会社 | 弾性線維形成促進剤 |
| FR2988606B1 (fr) * | 2012-03-30 | 2014-08-08 | Sederma Sa | Composition topique comprenant des oligosaccharides sulfates bioactifs et utilisations cosmetiques |
| FR2989087B1 (fr) * | 2012-04-06 | 2016-01-01 | Greentech | Nouveaux composes oligosaccharides et leur utilisation cosmetique |
-
2014
- 2014-04-30 FR FR1453973A patent/FR3020570B1/fr active Active
-
2015
- 2015-04-30 EP EP15718939.0A patent/EP3137050B1/fr active Active
- 2015-04-30 RU RU2016146372A patent/RU2683567C2/ru active
- 2015-04-30 KR KR1020167032484A patent/KR20160145788A/ko not_active Application Discontinuation
- 2015-04-30 AU AU2015254602A patent/AU2015254602B2/en active Active
- 2015-04-30 MX MX2016014050A patent/MX2016014050A/es active IP Right Grant
- 2015-04-30 WO PCT/EP2015/059544 patent/WO2015166063A1/fr active Application Filing
- 2015-04-30 US US15/307,681 patent/US9993417B2/en active Active
- 2015-04-30 CN CN201580023077.3A patent/CN106255490B/zh active Active
- 2015-04-30 BR BR112016024161-4A patent/BR112016024161B1/pt active IP Right Grant
- 2015-04-30 JP JP2016565157A patent/JP6625558B2/ja active Active
- 2015-04-30 CA CA2946943A patent/CA2946943C/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017514825A5 (ja) | ||
| RU2016146372A (ru) | Комбинация гиалуроновой кислоты и сульфатированного полисахарида | |
| Kumar et al. | Aloe vera: a potential herb and its medicinal importance. | |
| WO2008139122A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
| BRPI0507727A (pt) | composições para cuidado da pele | |
| WO2009053741A3 (en) | Novel formulation | |
| WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
| BR112015012565A2 (pt) | composto, composição cosmética ou farmacêutica, e, uso de um composto | |
| ES2361459A8 (es) | Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo. | |
| BR112015005339A8 (pt) | uso de óleo de semente de fruta milagrosa como um ingrediente ativo | |
| Fang et al. | The effectiveness of topical anti-scarring agents and a novel combined process on cutaneous scar management | |
| WO2008139123A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
| WO2008148966A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
| WO2012051614A3 (en) | Delivery of hydrophobic bioactive agents | |
| BR112013018365A2 (pt) | "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica" | |
| EP2407147A3 (en) | Composition with bio-rigenerative, restorative and eutrophying activity | |
| TN2015000282A1 (fr) | Composition dermatologique antimicrobienne topique | |
| WO2016185066A1 (es) | Procedimiento cosmético para reducir las arrugas de la piel | |
| SI1988909T1 (sl) | Uporaba polietilenglikola pri topičnih motnjah ali boleznih, povezanih z vnetjem, in zdravljenju ran | |
| RU2015142443A (ru) | Синергетическая комбинация аланин-глутамина, гиалуроновой кислоты и экстракта овса и ее применение в композиции для заживления ран и восстановления повреждений кожи | |
| RU2013130026A (ru) | Смеси карнозина и гиалуроновой кислоты и их применение | |
| WO2009147326A8 (fr) | Effets analgesiques de la toxine peptidique apetx2 | |
| WO2014127232A3 (en) | Methods for maintaining population of therapeutic cells in treatment site of subject in need of cell therapy | |
| DK2004235T3 (da) | Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse | |
| EP2810641A1 (en) | Topical pharmaceutical and medical device preparations containing combinations of sucralfate, hyaluronic acid, arginine and a natural moisturizing agent |